The U.S. Department of Transportation (DOT) has issued new Part 40 Question and Answer guidance clarifying how federally regulated drug testing rules apply in light of recent changes to marijuana’s classification under federal law. The guidance reinforces strict federal standards and has important implications for safety‑sensitive employers subject to DOT drug and alcohol testing regulations.
Employers and Workforces Impacted
The guidance applies to employers regulated under 49 C.F.R. Part 40, including those in transportation industries that require federally mandated drug testing for safety‑sensitive positions, such as:
- Aviation, trucking, rail, public transit, and pipeline operators;
- Employers regulated by agencies such as the FAA, FMCSA, FRA, FTA, and PHMSA; and
- Employees performing safety‑sensitive functions, including drivers, pilots, mechanics, and others subject to DOT testing requirements.
These employers must comply with federal drug testing rules regardless of differing state laws.
Key Clarification: Marijuana Positives Cannot Be “Reversed”
The central takeaway from the guidance is clear:
- A laboratory‑confirmed marijuana positive test result cannot be verified as negative by a Medical Review Officer (MRO) based on an employee’s claim that the result came from state‑legal marijuana use.
This remains true even in light of the federal government’s rescheduling of certain marijuana‑related substances.
State‑Legal Marijuana Is Not a Valid Medical Explanation
The DOT specifically clarified that:
- State‑licensed marijuana products do not qualify as FDA‑approved drugs; and
- Use of such products cannot constitute a “legitimate medical explanation” under federal drug testing rules.
Even where employees provide documentation such as:
- Medical marijuana cards;
- Physician recommendations; or
- Dispensary records
these materials do not satisfy federal requirements for overturning a positive result.
Federal Compliance Overrides State Law
The guidance reinforces that:
- DOT drug testing rules are governed by federal law, which continues to treat marijuana use as incompatible with safety‑sensitive duties; and
- Employers must apply uniform federal standards, regardless of state legalization or medical marijuana programs.
As a result, employees who test positive for marijuana remain subject to removal from safety‑sensitive functions and other required consequences under DOT regulations.
Role of the Medical Review Officer (MRO)
The guidance also clarifies the MRO’s role:
- MROs may only verify a positive test as negative where there is a valid prescription for an FDA‑approved controlled substance;
- Marijuana use, even if legal under state law, does not meet this standard; and
- MROs must therefore verify such results as positive when confirmed by a laboratory.
Employer Takeaway
The DOT’s updated guidance underscores that federal drug testing rules remain unchanged despite evolving state marijuana laws and federal rescheduling developments.
Employers subject to DOT regulations should:
- Continue to enforce zero‑tolerance drug testing policies for safety‑sensitive employees consistent with Part 40;
- Train HR, compliance personnel, and managers on the continued inapplicability of state marijuana laws in this context;
- Ensure MRO processes strictly follow federal standards for verifying test results; and
- Communicate clearly to employees that state‑legal marijuana use does not protect against federal testing consequences.
The guidance highlights ongoing tension between state and federal marijuana laws and reinforces that, for regulated employers, federal compliance remains the controlling standard.